Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia/reperfusion
Fields of Study & Subjects
Apelin-related biomedical research
Cardiovascular Function and Risk Factors
Diabetes Treatment and Management
Publication details
- Journal / source
- Basic Research in Cardiology
- Publisher
- Springer Science and Business Media LLC
- Volume
- 121
- Issue
- 3
- Pages
- 371–393
- Publication date
- 17 April 2026
- Language
- EN